Beyond the Counter: Arming Pharmacists in the Fight Against Diabetes Inertia

CRANBURY, NJ – June 12, 2026 – In the ongoing battle against type 2 diabetes, a condition affecting millions, we often focus on breakthrough drugs and lifestyle interventions. Yet, a more insidious challenge quietly undermines our progress: clinical inertia. It’s a term that describes a gap between knowledge and action—a failure to intensify treatment when a patient’s health goals aren't being met. This inaction, often born from a complex mix of system-level, provider, and patient barriers, leaves individuals vulnerable to the devastating long-term complications of uncontrolled diabetes.

But what if a key part of the solution was already embedded in nearly every community, waiting to be fully activated? New research presented at the prestigious American Diabetes Association (ADA) 2026 Scientific Sessions by Pharmacy Times Continuing Education™ (PTCE) suggests just that. By strategically empowering pharmacists, we can begin to dismantle this critical barrier, transforming a point of transaction into a nexus of proactive care.

The Anatomy of Inaction

To appreciate the significance of PTCE's findings, one must first understand the gravity of clinical inertia. It is not a simple oversight but a multifaceted problem. Research shows that in the United States, rates of clinical inertia in diabetes care can be alarmingly high, sometimes exceeding 80% in certain patient populations. The consequence is a prolonged period of poor glycemic control, which directly correlates with a higher risk of heart attacks, strokes, kidney failure, and nerve damage.

The causes are deeply woven into the fabric of our healthcare system. Providers, juggling heavy caseloads, may hesitate to add new medications for fear of side effects or uncertainty about rapidly evolving treatment guidelines. Patients face their own hurdles, including the high cost of medications, competing life priorities, and a limited understanding of their condition. Systemic issues, like insurance red tape and fragmented communication between care teams, add another layer of complexity. It is within this tangled web that therapeutic momentum is lost.

A New Blueprint for Education

The study presented by PTCE, titled “Real-World Barriers Contributing to Clinical Inertia in Type 2 Diabetes: A Pharmacist-Focused Educational Outcomes Study,” offers a compelling model for how to cut through this complexity. Instead of deploying a one-size-fits-all educational program, the researchers began by asking a simple, powerful question: What are the real-world challenges pharmacists face?

Through pre-program surveys of hundreds of pharmacists, they identified the most significant obstacles. The answers were not surprising, but they were specific: 41% pointed to insurance and medication access issues, while 37% cited patient adherence and lifestyle factors. Armed with this data, PTCE designed a targeted, case-based educational initiative that addressed these problems head-on. The results were remarkable. Following the program, pharmacists demonstrated significant improvements in confidence and competence. Most tellingly, 100% of participants reported an intent to change their daily practice.

“There are so many contributing factors to therapeutic inertia that lead to suboptimal outcomes in people with diabetes,” said Diana Isaacs, PharmD, a key developer of the study. “One of them is keeping up with the guidelines and knowing how to apply them in practice, especially when real-life people are more complicated and guidelines need to be applied with nuance. Our findings support the use of targeted, case-based, interactive sessions to increase knowledge and practice readiness.”

The Pharmacist as a Community Health Pillar

This study does more than validate an educational strategy; it champions a fundamental shift in our perception of the pharmacist's role. For too long, they have been seen primarily as dispensers of medication. This research reinforces what many in healthcare have increasingly recognized: pharmacists are one of our most accessible and underutilized clinical assets. They are indispensable members of the interprofessional care team.

Think about the barriers identified in the study. Who is better positioned to help a patient navigate insurance formularies or find cost-saving programs? Who has the repeated, direct contact necessary to counsel a patient on medication adherence and address their concerns about side effects? The community pharmacist. As Dr. Isaacs noted, “Pharmacists are important members of the interprofessional team and can be used to leverage closer follow-up and medication management.”

The initiative demonstrates the profound impact of investing in this frontline workforce. “This study highlighted the impact that PTCE's targeted, case-based education can have on improving care for people living with type 2 diabetes,” said Jim Palatine, RPh, MBA, President of PTCE. This is institutional innovation in its purest form—identifying a critical leverage point within the system and providing the precise tools needed to amplify its positive impact.

From Knowing to Doing

Perhaps the most crucial insight from the PTCE study is its approach to adult learning. The world of professional development is littered with continuing education programs that successfully impart knowledge but fail to change behavior. Healthcare is no exception. Other studies have shown that clinicians often have adequate knowledge of guidelines but still exhibit clinical inertia, highlighting a persistent gap between knowing and doing.

The PTCE model bridges this gap. By tailoring content to the specific, pre-identified needs of its audience, it ensures relevance. By using interactive, case-based discussions, it moves beyond passive memorization to active problem-solving. This is the key to creating lasting change.

“By identifying pharmacists’ lowest areas of confidence and knowledge pre-program, we were able to tailor the educational program to reflect real-world challenges,” explained Brianna Winters, Director of Medical Writing at PTCE. The goal, she added, was to move learners “past reactive diabetes management” and provide a framework for “proactive clinical decision-making.”

This approach represents a powerful departure from traditional education. It acknowledges that effective service isn't just about having information; it's about having the confidence and competence to apply that information within the messy, unpredictable context of real-world patient care. By investing in this deeper level of professional development, we empower our healthcare providers to not only know what to do but to feel ready and able to do it. This is how we build a more connected, effective, and equitable system of care, one community and one pharmacist at a time.